Kalaris Therapeutics Inc
KLRSNASDAQHealthcare● Active
$4.20
+$0.03(+0.65%)
Market Cap$78500825
P/E Ratio—
52W High$11.88
52W Low$2.14
Kalaris Therapeutics Inc（KLRS）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · KLRS · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.03B | $0.01B | $0.01B | $0.01B | $0.12B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.05B | $0.06B | $0.01B | $0.01B | $0.17B |
| Operating Income | ($0.05B) | ($0.06B) | ($0.01B) | ($0.01B) | ($0.17B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.01B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.04B) | ($0.06B) | ($0.01B) | ($0.02B) | ($0.17B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.04B) | ($0.06B) | ($0.01B) | ($0.02B) | ($0.17B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.85 | $-11.73 | $-42.09 | $-50.62 | $-63.00 |
| Wtd Avg Shares | 0.02B | 0.01B | 0.00B | 0.00B | 0.00B |
| EBITDA | ($0.05B) | ($0.06B) | ($0.01B) | ($0.02B) | ($0.17B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · B
深入了解Kalaris Therapeutics Inc
关于Kalaris Therapeutics Inc（KLRS）损益表
Kalaris Therapeutics Inc（KLRS）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，KLRS实现营收$0.00B，毛利润($0.00B)（毛利率—），净利润($0.04B)（净利率—）。
常见问题
KLRS · 4 问Kalaris Therapeutics Inc（KLRS）2025财年营收为$0.00B，同比down—%。
KLRS revenueKLRS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09